1-(5-FLUORO-URACILYL-1)-2,5-DI-O-ACETYL-B-D-GLUCOFURANURONO-6,3-LACTONE ET SON APPLICATION EN THERAPEUTIQUE

L'invention concerne un nouveau dérivé de 5-fluoro-uracile, plus précisément la 1-(5-fluoro-uracilyl-1)-2,5-di-O-acétyl- beta -D-glucofuranurono-6,3-lactone, possédant une action antiblastique. Cette substance indiquée répond à la formule : 1-(5-Fluoruacil-1)-2,5-di-O-acetyl- beta -D-glucofuran...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: RUTA ALBERTOVNA PAEGLE, MARGER JURIEVICH LIDAKA, REGINA ABRAMOVNA ZHUK, JURIS ARNOLDOVICH MAURINSH, AINA AVGUSTOVNA ZIDERMANE ET MARITE KARLOVNA KILEVITSA
Format: Patent
Sprache:fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator RUTA ALBERTOVNA PAEGLE, MARGER JURIEVICH LIDAKA, REGINA ABRAMOVNA ZHUK, JURIS ARNOLDOVICH MAURINSH, AINA AVGUSTOVNA ZIDERMANE ET MARITE KARLOVNA KILEVITSA
description L'invention concerne un nouveau dérivé de 5-fluoro-uracile, plus précisément la 1-(5-fluoro-uracilyl-1)-2,5-di-O-acétyl- beta -D-glucofuranurono-6,3-lactone, possédant une action antiblastique. Cette substance indiquée répond à la formule : 1-(5-Fluoruacil-1)-2,5-di-O-acetyl- beta -D-glucofuranurono-6,3-lactone has the formula Said substance has a marked antiblastic action. The substance is less toxic compared with the known preparation of similar action.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_FR2399440A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>FR2399440A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_FR2399440A13</originalsourceid><addsrcrecordid>eNqNirsKwjAUQLs4iPoPGRV6wb6EjjG9sYGQW-PN4FSKxEXRQv1_7OAHOJ3D4SyTRwbbCrQN5AmCl8rYq4VsB3laQWOAQCrkOR2hgZMNivR8ueDJERzSAqxUTA4FsriQE7LrrFGSzezoBLfoZYeBzTngOlnch-cUNz-uEqGRVQtxfPdxGodbfMVPr31e1HVZ7mVW_LF8AabWNRw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>1-(5-FLUORO-URACILYL-1)-2,5-DI-O-ACETYL-B-D-GLUCOFURANURONO-6,3-LACTONE ET SON APPLICATION EN THERAPEUTIQUE</title><source>esp@cenet</source><creator>RUTA ALBERTOVNA PAEGLE, MARGER JURIEVICH LIDAKA, REGINA ABRAMOVNA ZHUK, JURIS ARNOLDOVICH MAURINSH, AINA AVGUSTOVNA ZIDERMANE ET MARITE KARLOVNA KILEVITSA</creator><creatorcontrib>RUTA ALBERTOVNA PAEGLE, MARGER JURIEVICH LIDAKA, REGINA ABRAMOVNA ZHUK, JURIS ARNOLDOVICH MAURINSH, AINA AVGUSTOVNA ZIDERMANE ET MARITE KARLOVNA KILEVITSA</creatorcontrib><description>L'invention concerne un nouveau dérivé de 5-fluoro-uracile, plus précisément la 1-(5-fluoro-uracilyl-1)-2,5-di-O-acétyl- beta -D-glucofuranurono-6,3-lactone, possédant une action antiblastique. Cette substance indiquée répond à la formule : 1-(5-Fluoruacil-1)-2,5-di-O-acetyl- beta -D-glucofuranurono-6,3-lactone has the formula Said substance has a marked antiblastic action. The substance is less toxic compared with the known preparation of similar action.</description><language>fre</language><subject>CHEMISTRY ; DERIVATIVES THEREOF ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; NUCLEIC ACIDS ; NUCLEOSIDES ; NUCLEOTIDES ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SUGARS</subject><creationdate>1979</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19790302&amp;DB=EPODOC&amp;CC=FR&amp;NR=2399440A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19790302&amp;DB=EPODOC&amp;CC=FR&amp;NR=2399440A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>RUTA ALBERTOVNA PAEGLE, MARGER JURIEVICH LIDAKA, REGINA ABRAMOVNA ZHUK, JURIS ARNOLDOVICH MAURINSH, AINA AVGUSTOVNA ZIDERMANE ET MARITE KARLOVNA KILEVITSA</creatorcontrib><title>1-(5-FLUORO-URACILYL-1)-2,5-DI-O-ACETYL-B-D-GLUCOFURANURONO-6,3-LACTONE ET SON APPLICATION EN THERAPEUTIQUE</title><description>L'invention concerne un nouveau dérivé de 5-fluoro-uracile, plus précisément la 1-(5-fluoro-uracilyl-1)-2,5-di-O-acétyl- beta -D-glucofuranurono-6,3-lactone, possédant une action antiblastique. Cette substance indiquée répond à la formule : 1-(5-Fluoruacil-1)-2,5-di-O-acetyl- beta -D-glucofuranurono-6,3-lactone has the formula Said substance has a marked antiblastic action. The substance is less toxic compared with the known preparation of similar action.</description><subject>CHEMISTRY</subject><subject>DERIVATIVES THEREOF</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>NUCLEIC ACIDS</subject><subject>NUCLEOSIDES</subject><subject>NUCLEOTIDES</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SUGARS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1979</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNirsKwjAUQLs4iPoPGRV6wb6EjjG9sYGQW-PN4FSKxEXRQv1_7OAHOJ3D4SyTRwbbCrQN5AmCl8rYq4VsB3laQWOAQCrkOR2hgZMNivR8ueDJERzSAqxUTA4FsriQE7LrrFGSzezoBLfoZYeBzTngOlnch-cUNz-uEqGRVQtxfPdxGodbfMVPr31e1HVZ7mVW_LF8AabWNRw</recordid><startdate>19790302</startdate><enddate>19790302</enddate><creator>RUTA ALBERTOVNA PAEGLE, MARGER JURIEVICH LIDAKA, REGINA ABRAMOVNA ZHUK, JURIS ARNOLDOVICH MAURINSH, AINA AVGUSTOVNA ZIDERMANE ET MARITE KARLOVNA KILEVITSA</creator><scope>EVB</scope></search><sort><creationdate>19790302</creationdate><title>1-(5-FLUORO-URACILYL-1)-2,5-DI-O-ACETYL-B-D-GLUCOFURANURONO-6,3-LACTONE ET SON APPLICATION EN THERAPEUTIQUE</title><author>RUTA ALBERTOVNA PAEGLE, MARGER JURIEVICH LIDAKA, REGINA ABRAMOVNA ZHUK, JURIS ARNOLDOVICH MAURINSH, AINA AVGUSTOVNA ZIDERMANE ET MARITE KARLOVNA KILEVITSA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_FR2399440A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>fre</language><creationdate>1979</creationdate><topic>CHEMISTRY</topic><topic>DERIVATIVES THEREOF</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>NUCLEIC ACIDS</topic><topic>NUCLEOSIDES</topic><topic>NUCLEOTIDES</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SUGARS</topic><toplevel>online_resources</toplevel><creatorcontrib>RUTA ALBERTOVNA PAEGLE, MARGER JURIEVICH LIDAKA, REGINA ABRAMOVNA ZHUK, JURIS ARNOLDOVICH MAURINSH, AINA AVGUSTOVNA ZIDERMANE ET MARITE KARLOVNA KILEVITSA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>RUTA ALBERTOVNA PAEGLE, MARGER JURIEVICH LIDAKA, REGINA ABRAMOVNA ZHUK, JURIS ARNOLDOVICH MAURINSH, AINA AVGUSTOVNA ZIDERMANE ET MARITE KARLOVNA KILEVITSA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>1-(5-FLUORO-URACILYL-1)-2,5-DI-O-ACETYL-B-D-GLUCOFURANURONO-6,3-LACTONE ET SON APPLICATION EN THERAPEUTIQUE</title><date>1979-03-02</date><risdate>1979</risdate><abstract>L'invention concerne un nouveau dérivé de 5-fluoro-uracile, plus précisément la 1-(5-fluoro-uracilyl-1)-2,5-di-O-acétyl- beta -D-glucofuranurono-6,3-lactone, possédant une action antiblastique. Cette substance indiquée répond à la formule : 1-(5-Fluoruacil-1)-2,5-di-O-acetyl- beta -D-glucofuranurono-6,3-lactone has the formula Said substance has a marked antiblastic action. The substance is less toxic compared with the known preparation of similar action.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language fre
recordid cdi_epo_espacenet_FR2399440A1
source esp@cenet
subjects CHEMISTRY
DERIVATIVES THEREOF
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SUGARS
title 1-(5-FLUORO-URACILYL-1)-2,5-DI-O-ACETYL-B-D-GLUCOFURANURONO-6,3-LACTONE ET SON APPLICATION EN THERAPEUTIQUE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T06%3A57%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=RUTA%20ALBERTOVNA%20PAEGLE,%20MARGER%20JURIEVICH%20LIDAKA,%20REGINA%20ABRAMOVNA%20ZHUK,%20JURIS%20ARNOLDOVICH%20MAURINSH,%20AINA%20AVGUSTOVNA%20ZIDERMANE%20ET%20MARITE%20KARLOVNA%20KILEVITSA&rft.date=1979-03-02&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EFR2399440A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true